Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing idiopathic membranous nephropathy

J Manos, C D Short, E J Acheson

    Clinical Nephrology
    |December 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis.

    The British journal of ophthalmology·2008
    Same author

    Tacrolimus monotherapy in renal transplantation: four-year data.

    Transplantation proceedings·2002
    Same author

    Clinical audit and long-term evaluation of renal transplant recipients.

    Transplantation·2002
    Same author

    Tacrolimus is not associated with gingival overgrowth in renal transplant patients.

    Journal of clinical periodontology·2001
    Same author

    The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.

    Journal of periodontology·2001
    Same author

    Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature.

    American journal of nephrology·2001

    Idiopathic membranous nephropathy (IMN) can spontaneously relapse years after remission, with renal biopsies showing identical lesions. Immunosuppressive therapy and immunogenetic markers did not predict these relapses, suggesting a complex disease course.

    Area of Science:

    • Nephrology
    • Immunology

    Background:

    • Idiopathic membranous nephropathy (IMN) is a leading cause of nephrotic syndrome in adults.
    • Spontaneous remission occurs in a significant proportion of IMN patients, but relapse is a known complication.

    Purpose of the Study:

    • To investigate the characteristics and clinical course of spontaneous relapses in patients with idiopathic membranous nephropathy.
    • To evaluate the impact of immunosuppressive therapy and immunogenetic markers on relapse patterns in IMN.

    Main Methods:

    • Retrospective analysis of 60 patients with IMN.
    • Review of clinical data, renal biopsy findings at relapse, and treatment history.
    • Analysis of immunogenetic markers (HLA A, B, DR) in relation to relapse.

    Main Results:

    Related Experiment Videos

    • Eight out of 60 patients experienced spontaneous relapse of proteinuria after remissions lasting 25 months to 30 years.
    • Renal biopsies at relapse showed histopathology identical to the original IMN lesion.
    • Immunosuppressive therapy in 6 patients did not alter remission or relapse patterns.
    • Immunogenetic markers did not differentiate relapsing from non-relapsing patients.
    • Outcomes at study end included second remission, death from myocardial infarction during relapse, persistent nephrotic syndrome, or mild renal insufficiency.

    Conclusions:

    • Spontaneous relapses in idiopathic membranous nephropathy can occur after long remission periods with unchanged histology.
    • Current immunosuppressive regimens and HLA typing do not appear to influence relapse occurrence or duration.
    • Relapses in IMN do not significantly alter the overall long-term prognosis compared to patients without relapse.